Back to Journals » OncoTargets and Therapy » Volume 15

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Total article views   HTML views PDF downloads Totals
7,852 Dovepress* 5,708+ 153 5,861
PubMed Central* 2,144 262 2,406
Totals 7,852 415 8,267
*Since 4 October 2022
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar